ClinicalTrials.Veeva

Menu

Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer

A

Anandasabapathy, Sharmila, M.D.

Status and phase

Completed
Early Phase 1

Conditions

Squamous Cell Cancer

Treatments

Drug: proflavine

Study type

Interventional

Funder types

Other

Identifiers

NCT01384708
GCO# 10-0982

Details and patient eligibility

About

The overall objective of this study is to determine whether high-resolution imaging of the esophagus during routine diagnostic upper endoscopy can assist clinicians in detecting and discriminating dysplastic (precancerous) areas. This high-resolution microendoscope (HRME) was developed by our collaborators at Rice University and provides > 1000x magnified images of the esophageal mucosa. The purpose of this study is to determine whether this device can be used to enhance the diagnostic accuracy of routine endoscopic screening for squamous cell cancer of the esophagus.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • known or suspected squamous cell neoplasia
  • 18 years or older

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

70 participants in 1 patient group

treatment
Experimental group
Description:
imaging with proflavine
Treatment:
Drug: proflavine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems